FDA Inspection 1190814 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on Nov 17, 2022 in Houma, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Houma, LA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 98 | 21 CFR 606.100(c) | Thorough investigations |